S
Subhasish Mondal
Researcher at Jadavpur University
Publications - 15
Citations - 303
Subhasish Mondal is an academic researcher from Jadavpur University. The author has contributed to research in topics: Leishmania donovani & Amastigote. The author has an hindex of 7, co-authored 15 publications receiving 258 citations.
Papers
More filters
Journal ArticleDOI
One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis
TL;DR: New quercetin conjugated gold nanoparticles (QAunp) were successfully evaluated for the first time against leishmanial macrophage infections.
Journal ArticleDOI
Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.
TL;DR: TNPs (NP4) showed the highest drug loading, released the drug in a sustained manner for a prolonged period of time and were taken up well by the MCF-7 breast cancer cell line in vitro, suggesting the formulation may be suitable for breast cancer treatment due to the good permeation of the formulation into the breast cancer cells.
Journal ArticleDOI
In vitro susceptibilities of wild and drug resistant leishmania donovani amastigote stages to andrographolide nanoparticle: role of vitamin E derivative TPGS for nanoparticle efficacy.
TL;DR: It can be concluded that the low-selectivity of AG in in vitro generated drug resistant and field isolated resistant strains was improved in case of AG nanomedicines designed with vitamin E TPGS.
Journal ArticleDOI
Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study
Gurudutta Pattnaik,Biswadip Sinha,Biswajit Mukherjee,Saikat Ghosh,Sandip Basak,Subhasish Mondal,Tanmoy Bera +6 more
TL;DR: Experimental nanoparticles successfully transported didanosine to macrophages in vitro, suggesting reduction of dose, thus minimising toxicity and side effects, and developed nanoparticle may control HIV infection effectively at an early stage.
Journal ArticleDOI
In Vitro susceptibilities of wild and drug resistant Leishmania donovani amastigotes to piperolactam A loaded hydroxypropyl-β-cyclodextrin nanoparticles.
Plaban Bhattacharya,Plaban Bhattacharya,Subhasish Mondal,Souvik Basak,Pradeep Das,Achintya Saha,Tanmoy Bera +6 more
TL;DR: Piperolactam A (PL), a representative of the inchoate skeleton of aristolactAM chassis might be the source of safe and affordable antileishmanial agents for the cure of deadly Leishmania infections.